Playback speed
10 seconds
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOMA-3 Trials
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Luis Raez
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Luis Raez
0 views
June 14, 2024
Chapters
CROWN Trial & Lorlatinib FDA Approval
00:00
LAURA Study: Osimertinib in Stage III NSCLC
05:14
ADRIATIC: Durvalumab in Small Cell Lung Cancer
08:28
PALOMA Trial: Amivantamab Subcu vs IV
11:43
Survivability & Treatment Results Across Studies
14:47
Comments 1
Login to view comments.
Click here to Login